HTA NAT
Food supplement declared in France, declaration No 2019-4-755, decision dated 18 April 2019
HTA NAT (BIONOPS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- BIONOPS
- Food business operator placing the product on the market
- OLILUX Sarl
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 gélules
- Directions for use
- 2 gélules par jour
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Circulation sanguine et lymphatique
- Flavourings
- /
Declaration 295018, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Allium sativum L. | Bulbe | Extrait sec aqueux | 250 mg |
| Olea europaea L. | Fruit | Autre extrait sec | 150 mg |
| Crataegus laevigata (Poir.) DC. | Sommités fleuries | Extrait sec aqueux | 80 mg |
| Pinus pinaster Aiton | Ecorce | Extrait sec aqueux | 80 mg |
| Vaccinium myrtillus L. | Baie | Extrait sec hydroalcoolique | 80 mg |
Additives
E414
Other ingredients
Gélule végétale, Extrait de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
A déconseiller chez les personnes sous traitement anticoagulants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- HTA NAT BIONOPS, declared in 2017, withdrawn from the market : different composition: 9 ingredient(s) added, 4 missing
Brand : BIONOPS